Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia

被引:52
作者
Kim, S
Fotiadu, A
Kotoula, V
机构
[1] Univ Alabama, Dept Sci Biol, Tuscaloosa, AL 35487 USA
[2] BioPowerTech, Tuscaloosa, AL 35406 USA
[3] Aristotle Univ Thessaloniki, Dept Pathol, Sch Med, GR-54006 Thessaloniki, Greece
关键词
FasL; TL1A; LIGHT; inflammation; appendix;
D O I
10.1016/j.clim.2005.02.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Decoy receptor 3 (DcR3), a soluble receptor in the tumor necrosis factor (TNF) receptor family, is known to inhibit apoptosis mediated by pro-apoptotic TNF family cytokines such as Fas ligand (FasL), TL1A, and LIGHT. Therefore, the regulation of DcR3 expression under certain pathophysiological conditions is of interest since the level of soluble DcR3 would most likely affect the homeostasis of cells and tissues. We found that human intestinal epithelial cell (IEC) lines (SW480, SW620, and HT29) could selectively increase DcR3 release in response to lipopolysaccharide (LPS) and that all the cells preferentially expressed Toll-like receptor 4 (TLR-4). LPS-induced DcR3 releases in IECs appeared to be via the activation of mitogen-activated protein kinases (MAPK) such as extracellular signal-regulated kinase 1 and 2 (ERK1/2) and c-Jun NH2-terminal protein kinase (JNK), and the transcription factor NF-kappa B. Moreover, the increased expression of DcR3 in appendix epithelia from patients with acute appendicitis was demonstrated. Taken together, the results indicated that DcR3 might play an important role in the human intestinal epithelium during acute inflammatory processes caused by endotoxin challenge. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:286 / 294
页数:9
相关论文
共 44 条
[1]  
Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453
[2]   Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster [J].
Bai, C ;
Connolly, B ;
Metzker, ML ;
Hilliard, CA ;
Liu, XM ;
Sandig, V ;
Soderman, A ;
Galloway, SM ;
Liu, QY ;
Austin, CP ;
Caskey, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1230-1235
[3]   Toll-like receptor signaling pathways [J].
Barton, GM ;
Medzhitov, R .
SCIENCE, 2003, 300 (5625) :1524-1525
[4]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[5]   FR167653, a potent suppressant of interleukin-1 and tumor necrosis factor-α production, ameliorates colonic lesions in experimentally induced acute colitis [J].
Blandino, IIP ;
Otaka, M ;
Jin, M ;
Komatsu, K ;
Odashima, M ;
Konishi, N ;
Sato, T ;
Kato, S ;
Watanabe, S .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (10) :1105-1111
[6]   Quantification and detection of DcR3, a decoy receptor in TNFR family [J].
Chen, JG ;
Zhang, LR ;
Kim, S .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 285 (01) :63-70
[7]   Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity [J].
Chung, CS ;
Song, GY ;
Lomas, J ;
Simms, HH ;
Chaudry, IH ;
Ayala, A .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (03) :344-351
[8]  
Connolly K, 2001, J PHARMACOL EXP THER, V298, P25
[9]   Serum levels of the apoptosis-associated molecules, tumor necrosis factor-α/tumor necrosis factor type-l receptor and Fas/FasL, in sepsis [J].
De Freitas, I ;
Fernández-Somoza, M ;
Essenfeld-Sekler, E ;
Cardier, JE .
CHEST, 2004, 125 (06) :2238-2246
[10]   A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689